Investor Pau Hung To holds 12.75% of Advanced Biomed

Advanced Biomed Inc. (ADVB) reports that investor Pau Hung To, a citizen of the People's Republic of China, has filed a Schedule 13G indicating beneficial ownership of 176,225 shares of common stock.

Rhea-AI Filing Summary

Advanced Biomed Inc. (ADVB) reports that investor Pau Hung To, a citizen of the People's Republic of China, has filed a Schedule 13G indicating beneficial ownership of 176,225 shares of common stock. This represents 12.75% of Advanced Biomed's common shares outstanding.

The 176,225 shares reflect an original issuance of 4,405,625 shares to Pau Hung To on October 24, 2022 under a Debt-For-Equity Exchange Agreement dated June 30, 2022, in satisfaction of indebtedness owed by Advanced Biomed. The share amount has been adjusted solely for subsequent stock splits: a 4-for-1 forward split on May 16, 2023, a 1-for-5 reverse split on October 15, 2024, and a 1-for-20 reverse split on February 20, 2026. The reported 12.75% stake is based on 1,382,133 shares outstanding as of March 31, 2026. Pau Hung To reports sole voting and dispositive power over all 176,225 shares.

Key Figures

Beneficially owned shares: 176,225 shares Ownership percentage: 12.75% Shares outstanding: 1,382,133 shares +4 more

7 metrics

Beneficially owned shares 176,225 shares Common stock of Advanced Biomed Inc. reported on Schedule 13G

Ownership percentage 12.75% Percent of Advanced Biomed common stock class owned by Pau Hung To

Shares outstanding 1,382,133 shares Common stock outstanding as of March 31, 2026

Original shares issued in exchange 4,405,625 shares Shares issued on October 24, 2022 under Debt-For-Equity Exchange Agreement

Forward stock split ratio 4-for-1 Forward split effective May 16, 2023

First reverse stock split ratio 1-for-5 Reverse split effective October 15, 2024

Second reverse stock split ratio 1-for-20 Reverse split effective February 20, 2026

Key Terms

beneficially owned, Debt-For-Equity Exchange Agreement, forward split, reverse split

4 terms

beneficially owned financial

"Amount beneficially owned: 176,225 Based upon 4,405,625 shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Debt-For-Equity Exchange Agreement financial

"pursuant to a Debt-For-Equity Exchange Agreement dated June 30, 2022"

forward split financial

"as adjusted solely by reason of the Issuer's subsequent stock splits: 4-for-1 forward"

A forward split increases the number of a company’s shares by exchanging each existing share for multiple new shares, so each investor owns more pieces while their overall ownership stake and the company’s value stay the same. Think of cutting a pizza into more slices: each slice is smaller but you still have the same total; for investors this lowers the per‑share price, can make the stock feel more affordable, and often boosts trading activity and accessibility.

reverse split financial

"1-for-5 reverse on October 15, 2024 and 1-for-20 reverse"

A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much of Advanced Biomed Inc. (ADVB) does Pau Hung To own?

Pau Hung To beneficially owns 176,225 shares of Advanced Biomed Inc. common stock, representing 12.75% of the company’s outstanding shares, based on 1,382,133 shares outstanding as of March 31, 2026.

How did Pau Hung To acquire shares of Advanced Biomed Inc. (ADVB)?

Pau Hung To received 4,405,625 shares of Advanced Biomed common stock on October 24, 2022 under a Debt-For-Equity Exchange Agreement, issued in satisfaction of indebtedness owed by Advanced Biomed.

What stock splits has Advanced Biomed Inc. (ADVB) undertaken affecting this 13G holding?

The holding reflects adjustments for a 4-for-1 forward split on May 16, 2023, a 1-for-5 reverse split on October 15, 2024, and a 1-for-20 reverse split on February 20, 2026, applied to the original issuance.

What is the total share count used to calculate Pau Hung To’s 12.75% stake in ADVB?

The 12.75% ownership is calculated using 1,382,133 shares of Advanced Biomed common stock outstanding as of March 31, 2026, as reported in the company’s Form 10-Q for that period.

Does Pau Hung To share voting or dispositive power over ADVB shares?

No. The filing states that Pau Hung To has sole voting power and sole dispositive power over all 176,225 shares of Advanced Biomed common stock, with no shared voting or dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 12:56 PM EDT Accepted by SEC EDGAR 08/20/2026 - 12:55 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Advanced Biomed Inc.

(Name of Issuer)

Common Stock par value $0.001

(Title of Class of Securities)

00752P203

(CUSIP Number)

10/24/2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 00752P203

1

Names of Reporting Persons

Pau Hung To

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CHINA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 176,225.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 176,225.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

176,225.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

12.75 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Advanced Biomed Inc.
(b)	Address of issuer's principal executive offices: No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan
Item 2.
(a)	Name of person filing: HUNG TO PAU
(b)	Address or principal business office or, if none, residence: Flat B, 7/F, Block B Yick Fung Garden, 60 Praya Kennedy Town, Hong Kong
(c)	Citizenship: HUNG TO PAU is a citizen of People's Republic of China
(d)	Title of class of securities: Common Stock par value $0.001
(e)	CUSIP Number(s): 00752P203
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 176,225 Based upon 4,405,625 shares of Common Stock issued to the Reporting Person on October 24, 2022 pursuant to a Debt-For-Equity Exchange Agreement dated June 30, 2022, in satisfaction of indebtedness owed by the Issuer to the Reporting Person, as adjusted solely by reason of the Issuer's subsequent stock splits: 4-for-1 forward on May 16, 2023, 1-for-5 reverse on October 15, 2024 and 1-for-20 reverse on February 20, 2026.
(b)	Percent of class: 12.75% Based upon 1,382,133 shares of Common Stock outstanding as of March 31, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, filed with the SEC on May 15, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 176,225
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 176,225
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Pau Hung To

Signature:	/s/ Pau Hung To
Name/Title:	Pau Hung To
Date:	08/20/2026